Prestigious Prize Recognizes Groundbreaking Body's Defenses Research

The Nobel Prize in Physiology or Medicine has been awarded for transformative findings that illuminate how the immune system targets harmful pathogens while sparing the body's own cells.

A trio of renowned scientists—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research uncovered unique "security guards" within the immune system that eliminate malfunctioning defense cells that could harming the body.

The discoveries are now enabling innovative treatments for autoimmune diseases and cancer.

The winners will share a prize fund valued at 11m SEK.

Decisive Discoveries

"Their research has been decisive for comprehending how the immune system functions and the reason we do not all suffer from severe autoimmune diseases," commented the head of the Nobel Committee.

The trio's research explain a core question: In what way does the defense system protect us from countless infections while keeping our healthy cells unharmed?

Our body's protection system employs white blood cells that search for indicators of infection, even viruses and bacteria it has not met before.

These cells utilize detectors—called recognition units—that are generated randomly in a vast number of combinations.

This provides the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism unavoidably produces white blood cells that can attack the host.

Security Guards of the Immune System

Researchers earlier understood that a portion of these problematic defense cells were eliminated in the thymus—the site where immune cells develop.

The latest award recognizes the identification of T-reg cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize other immune cells that attack the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel added, "The findings have established a new field of investigation and accelerated the creation of innovative therapies, for example for tumors and immune disorders."

Regarding cancer, T-regs block the system from fighting the tumor, so studies are focused on reducing their quantity.

In autoimmune diseases, trials are testing increasing regulatory T-cells so the organism is no longer being harmed. A comparable approach could also be useful in minimizing the chances of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus extracted, causing self-attack conditions.

The researcher showed that injecting defense cells from healthy animals could stop the disease—suggesting there was a mechanism for preventing defenders from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an genetic immune disorder in rodents and humans that led to the discovery of a genetic factor critical for the way regulatory T-cells function.

"Their pioneering work has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly targeting the healthy cells," commented a prominent biological science expert.

"The work is a remarkable example of how fundamental physiological study can have broad implications for public health."